top of page

Unlocking the Future of Cell & Gene Therapies

logo-volnay-v4.png

ABOUT

We are building transformative cell & gene therapy ventures

team-01.png

Stefan Wildt, PhD

CEO, CO-FOUNDER

Takeda R&D CTO, CGTx development, Biopharma executive  leadership

  • LinkedIn
team-03.png

Nebojsa Milovic, PhD

CTO, CO-FOUNDER

CGTx development, manufacturing and tech innovation

  • LinkedIn
team-02.png

Ulrik Nielsen, PhD 

EXECUTIVE CHAIR,

CO-FOUNDER

Multi-time founder, Merrimack, Torque, Notch, Tidal

  • LinkedIn
team-06.png

Johannes Fruehauf, MD PhD 

PRESIDENT, CO-FOUNDER

Venture capital, biotech entrepreneur

  • LinkedIn

TEAM

We are experienced cell therapy developers, innovators, and company builders

TRACK RECORD

Decades of leading the Cell & Gene frontline

OUR INVESTORS

Empowering Innovation Together

Contact us

Light Strokes
Partner-logo-01.png
Partner-logo-02.png
Partner-logo-03.png
human immune cells in dark blue, light blue and purple tones.jpg

We are biotech venture builders with decades of experience in cell & gene therapies. We scout for novel ideas and breakthrough technologies, and we invest in those with disruptive, high-value potential.

 

With focus on product development and manufacturing innovation, we provide both capital and operational expertise to our ventures. Our goal is to accelerate their progress, ensuring they achieve preclinical proof-of-concept and clinical validation.

 

Our hub-and-spoke model optimizes resource allocation by centralizing capital, expertise, and talent across multiple assets. This efficient approach enables us to drive projects towards value inflection points while minimizing costs.

 

By mitigating clinical risks and validating our ventures' commercial potential, we create substantial value for our investors and patients alike.

BUILDING TEAMS & COMPANIES

Built and led high-performing CGTx teams and startups

C suite Pharma leadership of global 1000+ people teams

Established in international markets (US, JP, EU)

ESTABLISHING CAPABILITIES

Successful academic partnerships & strong network of innovators

Built & led CMC labs & GMP operations

Enabled partnerships with CDMOs and suppliers

Created and employed lab automation and industry 4.0 tech

DELIVERING PRODUCTS & TECH

APPROVED PRODUCTS 

Kymriah®, Abecma®, Alofisel®

INDs 

CARTs, CAR-NKs, iPSCs, γδT, HSCs, MSCs

MFRG. AUTOMATION

Automated cell processing, smart bioreactors, gene delivery, fill & finish

EXITS 

Tidal Therapeutics, GlycoFi

bottom of page